Morgan Stanley Direxion Daily S&P Biotech Bea Transaction History

Morgan Stanley

$1.36 Trillion
Q1 2025

A detailed history of Morgan Stanley transactions in Direxion Daily S&P Biotech Bea stock. As of the latest transaction made, Morgan Stanley holds 8,940 shares of LABD stock, worth $60,255. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,940

Previous 8,607 3.87%

Holding current value

$60,255

Previous $62,000 35.48%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$6.15 - $9.43 $2,047 - $3,140	333 Added 3.87%	8,940 $84,000
Q4 2024 Feb 14, 2025	BUY	$4.98 - $7.44 $1,658 - $2,477	333 Added 4.02%	8,607 $62,000
Q3 2024 May 14, 2025	SELL	$5.29 - $7.77 $60,893 - $89,440	-11,511 Reduced 58.18%	8,274 $48,000
Q3 2024 Nov 14, 2024	SELL	$5.29 - $7.77 $60,893 - $89,440	-11,511 Reduced 58.18%	8,274 $48,000
Q2 2024 May 14, 2025	BUY	$7.1 - $11.03 $79,363 - $123,293	11,178 Added 129.87%	19,785 $145,000
Q2 2024 Oct 17, 2024	BUY	$7.1 - $11.03 $29,607 - $45,995	4,170 Added 26.71%	19,785 $145,000
Q2 2024 Aug 14, 2024	BUY	$7.1 - $11.03 $29,607 - $45,995	4,170 Added 26.71%	19,785 $145,000
Q1 2024 Oct 17, 2024	SELL	$5.9 - $10.3 $24,603 - $42,951	-4,170 Reduced 21.08%	15,615 $113,000
Q1 2024 Aug 16, 2024	BUY	$5.9 - $10.3 $64,905 - $113,310	11,001 Added 238.43%	15,615 $113,000
Q1 2024 May 15, 2024	BUY	$5.9 - $10.3 $64,905 - $113,310	11,001 Added 238.43%	15,615 $113,000
Q4 2023 Aug 16, 2024	SELL	$9.2 - $29.48 $139,573 - $447,241	-15,171 Reduced 76.68%	4,614 $44,000
Q4 2023 Feb 13, 2024	BUY	$9.2 - $29.48 $32,439 - $103,946	3,526 Added 324.08%	4,614 $44,000
Q3 2023 Nov 15, 2023	SELL	$13.11 - $21.68 $482,448 - $797,824	-36,800 Reduced 97.13%	1,088 $22,000
Q2 2023 Aug 14, 2023	BUY	$11.41 - $21.44 $334,552 - $628,642	29,321 Added 342.26%	37,888 $544,000
Q1 2023 May 15, 2023	SELL	$12.42 - $23.37 $79,065 - $148,773	-6,366 Reduced 42.63%	8,567 $176,000
Q4 2022 Feb 14, 2023	SELL	$16.5 - $25.25 $51,463 - $78,754	-3,119 Reduced 17.28%	14,933 $257,000
Q3 2022 Nov 14, 2022	BUY	$15.83 - $35.31 $242,848 - $541,690	15,341 Added 565.88%	18,052 $432,000
Q2 2022 Oct 27, 2022	SELL	$28.35 - $81.35 $1,275 - $3,660	-45 Reduced 1.63%	2,711 $106,000
Q2 2022 Aug 15, 2022	SELL	$28.35 - $81.35 $1,275 - $3,660	-45 Reduced 1.63%	2,711 $106,000
Q1 2022 Oct 27, 2022	BUY	$23.35 - $52.45 $1,050 - $2,360	45 Added 1.66%	2,756 $97,000
Q1 2022 May 13, 2022	SELL	$23.35 - $52.45 $135,523 - $304,419	-5,804 Reduced 67.8%	2,756 $97,000
Q4 2021 Feb 14, 2022	BUY	$16.9 - $29.73 $49,060 - $86,306	2,903 Added 51.32%	8,560 $220,000
Q3 2021 Nov 15, 2021	BUY	$17.17 - $26.91 $97,130 - $152,229	5,657 New	5,657 $120,000

Others Institutions Holding LABD

# of Institutions

Shares Held

1.45M

Call Options Held

1.02M

Put Options Held

148K

View Full List

About DIREXION DAILY S&P BIOTECH BEA

Ticker LABD
Sector ETFs
Industry ETFs

More about LABD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account